An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

A new robotic procedure is transforming how doctors detect and treat lung cancer, helping catch it earlier and improve ...

The Phase 3 failure has prompted Gilead Sciences and Arcus Biosciences to terminate a mid-stage study of their TIGIT asset in ...

Most of us probably have a solid, big picture idea of behavior that isn’t good for our bodies. Of course, human health is a ...

Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly ...

A new grant program in Syracuse is aimed at reducing barriers that can keep people from getting screened early, including ...

But in the last three years, the company has sought to leverage its footholds in China and the U.S. to become a multinational ...

Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung ...

Tin says in a social media post cancer cells were found in her lymph nodes, more than a year after she was diagnosed with ...

Arcus Biosciences (RCUS) traded lower in the premarket on Monday after the oncology-focused biotech announced the discontinuation of a late-stage trial designed to evaluate its anti-TIGIT therapy ...

The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung health by participating in the LUNG FORCE Walk on May 16. The 12th annual event ...

Nons=moker Dave Nitsche shares his journey of resilience and determination after a stage 4 lung cancer diagnosis.